Clinical trial
A Prospective, Multicenter, Randomized, Double-Blind, Two-Arm, Sham-Controlled, Parallel-Design Trial to Assess the Efficacy and Safety of Carpal Stim for Treating Carpal Tunnel Syndrome
NCT05497037 is registered in ClinicalTrials.gov with GiMer Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized, Double-Blind, Two-Arm, Sham-Controlled, Parallel-Design Trial to Assess the Efficacy and Safety of Carpal Stim for Treating Carpal Tunnel Syndrome
- Lead sponsor
- GiMer Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 9, 2022
- Completion date
- February 8, 2023
- Enrollment
- 58 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.